These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 1216049

  • 1. [Evaluation of the effectiveness of anginine treatment of diabetic microangiopathies].
    Spesivtseva VG, Frenkel' VKh, Mamaeva GG, Sokolovskiĭ GA, Kukes VG.
    Sov Med; 1975 Jul; (7):42-5. PubMed ID: 1216049
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
    Parodi FA, Caputo G.
    Clin Ter; 1976 Dec 31; 79(6):571-81. PubMed ID: 1009761
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P, Abbadessa V, Pecorella M, Cajozzo A.
    Boll Soc Ital Cardiol; 1977 Dec 31; 22(7):1036-41. PubMed ID: 618239
    [No Abstract] [Full Text] [Related]

  • 10. [The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
    Pola P.
    Minerva Cardioangiol; 1975 Apr 31; 23(4):261-9. PubMed ID: 1095958
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [The efficacy of pyridonolcarbamate in diabetic angiopathy].
    Furitano G, Cajozzo A, Notarbartolo A.
    Minerva Med; 1975 Dec 12; 66(85):4599-602. PubMed ID: 1196545
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Effect of anginine on the state of the stomach and pancreas in diabetes mellitus].
    Semichastnova AG, Golubiatnikova GA, Permiakov NK, Titova GP, Bokaneva IA.
    Sov Med; 1975 Oct 12; (10):36-42. PubMed ID: 1209326
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
    Bagliani A, Borri P, Parravicini R.
    Minerva Cardioangiol; 1975 Nov 12; 23(11):701-10. PubMed ID: 1223674
    [No Abstract] [Full Text] [Related]

  • 18. [Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)].
    Roztocil K, Oliva I, Linhart J, Prerovský I, Modr Z.
    Cas Lek Cesk; 1976 Aug 27; 115(33-34):1051-5. PubMed ID: 975177
    [No Abstract] [Full Text] [Related]

  • 19. [Evaluation of anginine in the treatment of cerebrovascular disorders (preliminary report)].
    Majkowski J.
    Neurol Neurochir Pol; 1975 Aug 27; 9(3):381-8. PubMed ID: 1153068
    [Abstract] [Full Text] [Related]

  • 20. [Hydroxyproline indicators before and after treatment of diabetic angiopathies].
    Spesivtseva VG, Mamaeva GG, Starosel'tseva LK, Tulemisov EU, Bokaneva IA.
    Ter Arkh; 1978 Aug 27; 50(1):93-7. PubMed ID: 635809
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.